Argent Biopharma: Half Yearly Report and Accounts

This information contained in this report should be read in conjunction with the most recent annual report. NET TANGIBLE ASSETS PER ORDINARY SHARE (cents) RESULTS FOR ANNOUNCEMENT TO MARKET No dividends have been paid or declared during the year DETAILS OF SUBSIDIARIES During the period, there were no newly incorporated nor newly acquired entities. In December 2025, the Group lost control of its S